Animal

Animal Biosciences is a biotechnology company focused on extending the healthy lifespan of companion animals through the application of longevity science. Founded as a subsidiary of Life Biosciences, the company leverages research into the fundamental mechanisms of aging, such as sirtuin activation and NAD+ restoration, to develop therapies for age-related diseases in pets. Their pipeline includes programs targeting cognitive dysfunction, mobility issues, and metabolic health in dogs and cats. By translating human longevity research into veterinary medicine, Animal Biosciences aims to delay the onset of chronic conditions and improve the quality of life for aging animals. The company operates at the intersection of geroscience and veterinary health, utilizing a platform-based approach to identify and validate therapeutic candidates.